23 research outputs found

    A Subset of CXCR5+CD8+ T Cells in the Germinal Centers From Human Tonsils and Lymph Nodes Help B Cells Produce Immunoglobulins

    Get PDF
    Recent studies indicated that CXCR5+CD8+ T cells in lymph nodes could eradicate virus-infected target cells. However, in the current study we found that a subset of CXCR5+CD8+ T cells in the germinal centers from human tonsils or lymph nodes are predominately memory cells that express CD45RO and CD27. The involvement of CXCR5+CD8+ T cells in humoral immune responses is suggested by their localization in B cell follicles and by the concomitant expression of costimulatory molecules, including CD40L and ICOS after activation. In addition, CXCR5+CD8+ memory T cells produced significantly higher levels of IL-21, IFN-γ, and IL-4 at mRNA and protein levels compared to CXCR5−CD8+ memory T cells, but IL-21-expressing CXCR5+CD8+ T cells did not express Granzyme B and perforin. When cocultured with sorted B cells, sorted CXCR5+CD8+ T cells promoted the production of antibodies compared to sorted CXCR5−CD8+ T cells. However, fixed CD8+ T cells failed to help B cells and the neutralyzing antibodies against IL-21 or CD40L inhibited the promoting effects of sorted CXCR5+CD8+ T cells on B cells for the production of antibodies. Finally, we found that in the germinal centers of lymph nodes from HIV-infected patients contained more CXCR5+CD8+ T cells compared to normal lymph nodes. Due to their versatile functional capacities, CXCR5+CD8+ T cells are promising candidate cells for immune therapies, particularly when CD4+ T cell help are limited

    Impurity Formation in the Beckmann Rearrangement of Cyclohexanone Oxime to Yield ε‑Caprolactam

    No full text
    The main impurities produced in the Beckmann rearrangement of cyclohexanone oxime (CHO) to yield ε-caprolactam (CPL) in oleum were identified as cyclohexanone, 2-cyclohexen-1-one, 2-hydroxycyclohexan-1-one, 1,2-cyclohexanedione, and 1,2,3,4,6,7,8,9-octahydrophenazine. The effects of several operating parameters on impurity formation were also investigated, including stirrer speed, acid/oxime ratio, SO<sub>3</sub> concentration, temperature, and CHO concentration. Although impurity formation is unavoidable in this process, the results indicated that impurity formation was generally reduced with an enhanced mixing performance, a higher acid/oxime ratio, and a higher SO<sub>3</sub> concentration, thereby indicating that these three factors play a key role in determining the impurities resulting from this transformation. Potential formation pathways for the impurities were also proposed and discussed based on the experimental results. These results are therefore expected to contribute to the development of guidelines for process design and reaction-condition optimization for the industrial production of CPL

    Antiangiogenesis Therapy of Endometriosis Using PAMAM as a Gene Vector in a Noninvasive Animal Model

    No full text
    Objective. To evaluate the characteristics and antiangiogenic effects of endostatin-loaded PAMAM on endometriosis in a noninvasive animal model. Materials and Methods. A noninvasive animal model was established by injecting adenovirus-GFP transfected endometrial stromal and glandular epithelial cells subcutaneously into nude mice. Endostatin-loaded PAMAM was prepared and identified by transmission electron microscopy. For in vitro studies, the DNA protection and cytotoxicity of PAMAM were investigated and compared with Lipofectamine 2000. For in vivo study, endostatin-loaded PAMAM was injected into the noninvasive model and evaluated by continuously observing the fluorescent lesion, lesion weight, microvessel density and VEGF immunostaining. Results. Compared with Lipofectamine 2000, PAMAM and HC PAMAM-ES group, MC PAMAM-ES group and LC PAMAM-ES group demonstrated a better stromal cells protective such that MC PAMAM-ES group of CCK8 was 0.617 ± 0.122 at 24 hr and 0.668 ± 0.143 at 48 hr and LC PAMAM-ES group of CCK8 was 0.499 ± 0.103 at 24 hr and 0.610 ± 0.080 at 48 hr in stromal cells (P<0.05) but similar cytotoxicity in glandular epithelial cells in vitro. After 16 hrs of digestion, DNA decreased slightly under the protection of PAMAM. Endostatin-loaded PAMAM of HD PAMAM-ES group and LD PAMAM-ES group inhibited the growth of the endometriotic lesion in vivo at days 15, 20, 25 and 30 detected by noninvasive observation after injecting one dose endostatin of various medicines into the endometrial lesion in each mouse on day 10 (P<0.05) and confirmed by lesion weight at day 30 with HD PAMAM-ES group being 0.0104 ± 0.0077 g and LD PAMAM-ES group being 0.0140 ± 0.0097 g (P<0.05). Immunohistochemistry results showed that endostatin-loaded PAMAM reduced the microvessel density 3.8 ± 2.4 especially in HD PAMAM-ES group in the lesion (P<0.05). Conclusion. Endostatin-loaded PAMAM inhibits the development of endometriosis through an antiangiogenic mechanism and can be observed through the noninvasive endometriosis model

    Additional file 2: Figure S2. of MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression

    No full text
    Confirmation of miR-381 low-expression in gastric cancer cells. QRT-PCR analysis of miR-381 transfection efficiency after antagomiR-381 and negative control transfection in MKN-28 and SGC-7901 cell lines. (TIF 29 kb

    Additional file 1: Figure S1. of MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression

    No full text
    Confirmation of miR-381 overexpression in gastric cancer cells. QRT-PCR analysis of miR-381 transfection efficiency after agomiR-381 and negative control transfection in AGS and BGC-823 cell lines. (TIF 31 kb
    corecore